In 2002, George Calin, Carlo Croce, and colleagues at Thomas Jefferson University provided the first evidence that microRNAs — small noncoding RNAs that can repress gene expression — were linked to cancer. 1 Since then, the field has mounted a massive effort to find out whether those links will be clinically useful.
Survey Series
For Advertisers
The Small Side of Cancer
Can microRNAs help diagnose, classify, and stage human cancers?
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.